P540: PEVONEDISTAT, AZACITIDINE AND VENETOCLAX FOR PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA– A PHASE I STUDY. (23rd June 2022) - Guru Murthy, G. S.; Kaufmann, S.; Saliba, A.; Szabo, A.; Michaelis, L.; Abedin, S.; Runaas, L.; Carlson, K.; Maldonado-Schmidt, S.; Hinman, A.; Thomas, A.; Baim, A.; et al.